Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXDX | QGEN | RVMD | ||
| Company | Prometheus Biosciences Inc | Qiagen N.V. | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 199.68 | 42.76 | 57.06 | ||
| High | 199.98 | 42.90 | 57.41 | ||
| Low | 199.60 | 42.55 | 56.39 | ||
| Last | 199.92 | 42.78 | 56.75 | ||
| Change | +0.18 | +0.45 | -0.03 | ||
| % Change | +0.09% | +1.06% | -0.05% | ||
| Volume | 1,860,600 | 679,900 | 1,165,800 | ||
| 20-Day Average Volume | 1,174,595 | 981,510 | 1,532,105 | ||
| Previous Close | 199.74 | 42.33 | 56.78 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 198.02 | 42.63 | 56.04 | ||
| 20-Day Raw Stochastic | 99.23% | 48.60% | 63.92% | ||
| 20-Day Relative Strength | 81.45% | 48.81% | 59.61% | ||
| Weighted Alpha | +110.70 | +1.77 | +151.73 | ||
| Today's Opinion | 100% Buy | 56% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.47% since 06/08/23 | +3.66% since 11/15/24 | +2.94% since 11/15/24 | ||
| Low | 198.91 on 06/09/23 | 40.35 on 11/19/24 | 53.69 on 11/18/24 | ||
| High | 199.98 on 06/15/23 | 42.90 on 11/22/24 | 58.83 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | +2.82% since 05/15/23 | +1.35% since 10/22/24 | +20.41% since 10/22/24 | ||
| Low | 189.76 on 05/16/23 | 40.35 on 11/19/24 | 45.99 on 10/23/24 | ||
| High | 199.98 on 06/15/23 | 45.35 on 11/07/24 | 62.40 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +72.97% since 03/15/23 | -8.43% since 08/22/24 | +31.18% since 08/22/24 | ||
| Low | 104.55 on 03/30/23 | 40.35 on 11/19/24 | 40.80 on 09/06/24 | ||
| High | 199.98 on 06/15/23 | 47.24 on 08/23/24 | 62.40 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +85.68% since 12/15/22 | -1.66% since 05/22/24 | +42.70% since 05/22/24 | ||
| Low | 103.33 on 01/06/23 | 39.73 on 07/09/24 | 36.48 on 06/17/24 | ||
| High | 199.98 on 06/15/23 | 47.44 on 08/22/24 | 62.40 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,558,772 | 9,762,524 | 9,546,428 | ||
| Shares Outstanding, K | 47,813 | 228,203 | 168,219 | ||
| Annual Sales | 6,810,000 | 1,965,310,000 | 11,580,000 | ||
| Annual Net Income | -141,750,000 | 341,300,000 | -436,370,000 | ||
| Last Quarter Sales | 1,110,000 | 501,870,000 | 0 | ||
| Last Quarter Net Income | -40,880,000 | 98,060,000 | -156,290,000 | ||
| 60-Month Beta | -0.49 | 0.41 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.86 on 05/09/23 | 0.57 on 11/06/24 | -0.94 on 11/06/24 | ||
| Latest Earnings Date | 08/10/23 | 11/06/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | 0.027 on 12/27/02 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.87 | 0.00 | ||